These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34891563)
21. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278 [TBL] [Abstract][Full Text] [Related]
22. Review of Self-Reported Data from UK Do-It-Yourself Artificial Pancreas System (DIYAPS) Users to Determine Whether Demographic of Population Affects Use or Outcomes. Street TJ Diabetes Ther; 2021 Jul; 12(7):1839-1848. PubMed ID: 34047963 [TBL] [Abstract][Full Text] [Related]
23. User-driven open-source artificial pancreas systems and patient-reported outcomes: A missed opportunity? Vallis M; Holt RIG Diabet Med; 2022 May; 39(5):e14797. PubMed ID: 35092089 [TBL] [Abstract][Full Text] [Related]
24. [What is the current state of the artificial pancreas in diabetes care?]. Dimou M; Laimer M; Stettler C; Bally L Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132 [TBL] [Abstract][Full Text] [Related]
25. In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems. Toffanin C; Kozak M; Sumnik Z; Cobelli C; Petruzelkova L Diabetes Technol Ther; 2020 Feb; 22(2):112-120. PubMed ID: 31769699 [No Abstract] [Full Text] [Related]
27. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development? Trevitt S; Simpson S; Wood A J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628 [TBL] [Abstract][Full Text] [Related]
29. Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Russell SJ Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927 [TBL] [Abstract][Full Text] [Related]
30. [From insulin pump and continuous glucose monitoring to the artificial pancreas]. Apablaza P; Soto N; Codner E Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340 [TBL] [Abstract][Full Text] [Related]
31. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705 [TBL] [Abstract][Full Text] [Related]
32. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine. Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis. Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535 [TBL] [Abstract][Full Text] [Related]
34. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874 [TBL] [Abstract][Full Text] [Related]
35. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Ekhlaspour L; Nally LM; El-Khatib FH; Ly TT; Clinton P; Frank E; Tanenbaum ML; Hanes SJ; Selagamsetty RR; Hood K; Damiano ER; Buckingham BA J Diabetes Sci Technol; 2019 Nov; 13(6):1001-1007. PubMed ID: 31470740 [TBL] [Abstract][Full Text] [Related]
36. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G. Jeyaventhan R; Gallen G; Choudhary P; Hussain S Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488 [TBL] [Abstract][Full Text] [Related]
37. Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study. Benhamou PY; Huneker E; Franc S; Doron M; Charpentier G; Acta Diabetol; 2018 Jun; 55(6):549-556. PubMed ID: 29520615 [TBL] [Abstract][Full Text] [Related]
38. Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data. Muñoz-Velandia O; Guyatt G; Devji T; Zhang Y; Li SA; Alexander PE; Henao D; Gomez AM; Ruiz-Morales Á Diabetes Technol Ther; 2019 Apr; 21(4):183-200. PubMed ID: 30839227 [TBL] [Abstract][Full Text] [Related]
39. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas. Ang KH; Tamborlane WV; Weinzimer SA Expert Opin Drug Deliv; 2015; 12(10):1579-82. PubMed ID: 26389567 [TBL] [Abstract][Full Text] [Related]